Alkem Laboratories Receives EU GMP Certificate for Daman Facility
Filing Summary
Alkem Laboratories Ltd has received a ‘Certificate of GMP Compliance of a Manufacturer’ from the Malta Medicines Authority for its manufacturing facility in Daman, India. The certificate is valid for three years from the inspection date of December 9, 2025. This update follows a previous intimation regarding a GMP inspection by the Malta Medicines Authority. The company has made this disclosure available on its website in compliance with SEBI regulations.
Alkem Laboratories Ltd has announced the receipt of a Certificate of GMP Compliance of a Manufacturer from the Malta Medicines Authority for its manufacturing facility located in Daman, India. The certificate is valid for a period of three years, starting from the inspection date of December 9, 2025.
This development follows an earlier intimation dated December 10, 2025, regarding a GMP inspection conducted by the Malta Medicines Authority at the Daman facility. The company has complied with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, by disclosing this information.
A copy of the disclosure has been made available on the company’s website as per Regulation 30(8) of the SEBI LODR Regulations. The company has requested that this information be taken on record by the relevant authorities.
Alkem Laboratories Ltd is focused on the development, manufacture, and marketing of pharmaceutical formulations and nutraceuticals. The company prioritizes compliance with international quality standards and regulatory requirements to maintain its position in the global pharmaceutical market.